Iatrogenic Adrenal Insufficiency How to Get Adrenals Working Again
Transl Pediatr. 2017 Oct; 6(iv): 269–273.
Recovery of steroid induced adrenal insufficiency
Areej K. Younes
oneDepartment of Endocrinology, Nationwide Children'south Hospital, Columbus, Ohio, United states;
Noor Chiliad. Younes
twoDivision of Pediatrics, King Hussein Cancer Middle, Amman, Hashemite kingdom of jordan
Received 2017 Aug 12; Accustomed 2017 Sep xvi.
Abstract
Secondary adrenal insufficiency tin result from insufficient stimulation of the adrenal glands due to inadequate secretion or synthesis of adrenocorticotropic hormone (ACTH). This can be caused by hypopituitarism, primal nervous arrangement injury (tumors, radiation, and surgery) or long-term glucocorticoid therapy. Glucocorticoids were introduced in the 1950s, and have been used for their anti-inflammatory and other pharmacological furnishings, and also every bit replacement therapy for adrenal insufficiency. Notwithstanding, chronic glucocorticoid utilize may atomic number 82 to suppression of the hypothalamic pituitary adrenal axis through negative feedback. This may lead to secondary adrenal insufficiency. Typically, the hypothalamic pituitary adrenal axis recovers after cessation of glucocorticoids, just the timing of recovery tin be variable and can take anywhere from half dozen–12 months. Understanding the effect of exogenous glucocorticoids on the hypothalamic pituitary adrenal axis, recovery of the axis, and tests used to assess the recovery, are crucial to avert prescribing unnecessary steroid replacement or missing a critical diagnosis with detrimental consequences.
Keywords: Adrenal insufficiency, glucocorticoid employ, stimulation test, adrenocorticotropic hormone (ACTH)
Introduction
Secondary adrenal insufficiency can result from inadequate stimulation of the adrenal glands due to either insufficiency or inadequate secretion of adrenocorticotropic hormone (ACTH). This may occur due to a variety of reasons including hypothalamic defects, hypopituitarism, defects in synthesis and processing of ACTH and chronic glucocorticoid apply. The mortality and morbidity associated with secondary adrenal insufficiency depends on the underlying etiology. However, missing the diagnosis could pb to detrimental consequences.
In improver to being used as a replacement therapy for adrenal insufficiency, glucocorticoids have been widely used for their anti-inflammatory and pharmacological effects in a variety of medical conditions. The hypothalamic-pituitary-adrenal (HPA) centrality tin can be suppressed after a single dose of steroid, simply typically recovers quickly. With chronic glucocorticoid, recovery of HPA axis might take longer. Agreement the timeline for recovery of the HPA axis and tests used to assess adrenal function and the HPA axis is crucial to both avoiding missing a diagnosis of adrenal insufficiency and the apply of unnecessary steroids for replacement therapy.
Underlying mechanism of steroid induced adrenal insufficiency
Steroidogenesis is controlled by multiple factors including the HPA centrality. ACTH, secreted by the anterior pituitary gland, stimulates synthesis of cortisol and androgens in the adrenal cortex. ACTH is besides thought to have an consequence on stimulating growth and maturation of the adrenal gland. In the absence of ACTH, the adrenal glands undergo cloudburst (i).
The HPA axis, like many endocrine systems, is a classic example of the feedback system ( Effigy 1 ). Glucocorticoids, whether endogenous or exogenous, exert negative feedback inhibition at the pituitary and hypothalamus levels. The glucocorticoid effects may exist divided into acute and delayed phases. The acute phase usually occurs within minutes after administration. This is related to the charge per unit of rise in cortisol level, and inhibits the release of ACTH and CRF from secretory granules. The delayed phase, on the other hand, occurs after ii–xx h and extends up to days. This phase is mainly related to the inhibition of factor transcription factors of the pro-opiomelanocortin (POMC), leading to decreased synthesis of ACTH. The delayed phase is dependent on the dose and elapsing of glucocorticoid use only typically occurs with chronic glucocorticoid employ. This explains the fact that although only i or two doses of glucocorticoid are sufficient to suppress the HPA centrality, the recovery is usually rapid. On the other hand, with prolonged use of glucocorticoids, the recovery of the HPA axis is much delayed (1,ii).
The figure demonstrates the hypothalamic-pituitary-adrenal axis. Both endogenous and exogenous glucocorticoids exert negative feedback event on both pituitary and hypothalamus levels. This negative feedback issue of exogenous glucocorticoid assistants may lead to secondary adrenal insufficiency. ACTH, adrenocorticotropic hormone; CRH, corticotropin releasing hormone.
Timing of recovery of HPA function
Glucocorticoids accept been used for their anti-inflammatory and pharmacological furnishings in multiple different disease entities including rheumatologic disorders, asthma, oncological disorders and many others. There are different studies that looked into effect of exogenous chronic glucocorticoid utilise on the HPA centrality, and timing of recovery. However, depending on the glucocorticoids formulation used, the duration of therapy, the employ of a variety of weaning protocols and the different diagnostic tests used to assess adrenal part, it is rather hard to draw general conclusions. In this review, we will focus on a few most common medical weather condition for which glucocorticoids are encountered in children.
Glucocorticoid use in childhood leukemia
Glucocorticoids have been widely used in the treatment of babyhood leukemia. These patients are at a high adventure for infectious complications, which makes identification of secondary adrenal insufficiency in these children disquisitional. At that place are multiple studies that looked into the effect of chronic glucocorticoid utilize on the HPA axis and timing of recovery in this population of patients. Felner et al. (3), evaluated 10 children with B cell acute lymphoblastic leukemia (ALL) who received 28 solar day-course of loftier dose dexamethasone. The recovery of adrenal part was assessed past performing a loftier dose (250 µg) ACTH stimulation test. All patients were noted to have testing consistent with adrenal insufficiency on twenty-four hour period 1 after cessation of glucocorticoid therapy. Time for recovery of the HPA axis ranged from 4–eight weeks. Mahachoklertwattana et al. (4), evaluated children with ALL who received induction therapy with prednisone for 28 days followed past seven days of dexamethasone for 4 weeks. Low dose ACTH stimulation examination was used to assess recovery of HPA axis. About patients showed recovery of the HPA axis by iv–12 weeks. Even so, xiii% of patients had persistent adrenal insufficiency at 20 weeks later receiving glucocorticoid therapy. Einaudi et al. (five), evaluated patients in two arms of glucocorticoid therapy. One arm received 22 days of prednisone tapering over nine days and the 2d grouping received 22 days of dexamethasone which was weaned over 9 days. All patients demonstrated recovery of HPA axis by 10 weeks. Based on the higher up studies, it appears that almost patients demonstrated recovery of HPA axis between 4–ten weeks after cessation of therapy.
Glucocorticoid employ in hemangioma
Glucocorticoids are widely used for treatment of hemangiomas in infants. Mendoza-Cruz et al. (6) looked into duration of HPA centrality suppression in infants treated with prednisolone. The infants received high dose of prednisolone for an average of 3–6 months, weaned over 4–6 weeks. Salivary cortisol was used to assess recovery of cyclic rhythm, as this would be the first sign of recovery of HPA axis. Cyclic rhythm was noted to be established by 6 weeks later on cessation of oral steroids. That was confirmed by low dose (ane µg) ACTH stimulation test. All infants recovered and none had persistent adrenal insufficiency by 10–12 weeks subsequently cessation of glucocorticoid therapy.
Glucocorticoid and childhood asthma
Inhaled corticosteroids (ICS) have been widely used in the treatment of persistent asthma for a long time. It was believed that when used within recommended doses, the risk for clinically relevant adrenal suppression is minimal (vii). Yet, with increasing case reports of adrenal insufficiency with the use of ICS, the importance of understanding the risk factors associated with HPA suppression have get more than obvious. In fact, some studies have shown that as many as 20–l% of children treated with ICS had biomedical abnormalities of the HPA axis (8). Fluticasone propionate is much more than likely to cause clinically symptomatic adrenal suppression compared to other ICS like beclomethasone, triamcinolone and budesonide. Dose of fluticasone of 352 µg per day were noted to result in adrenal suppression in about l% of patients (nine). Eid et al. evaluated children with asthma who were treated with inhaled fluticasone propionate (10). These patients had early morning cortisol levels assessed after using the medication for three–13 months. Seventeen percent of patients on low dose ICS had morning time cortisol levels of less than 5.5 µg/dL compared to 45% of children on the high dose. Those children who were switched to unlike formulations or lower doses were noted to demonstrate improvement in cortisol levels after irresolute the medication.
Breborowicz et al. evaluated patients with severe asthma receiving recommended doses of ICS of 500–1,000 µg/mean solar day of fluticasone propionate or the equivalent of budesonide (one,000–ii,000 µg/day) for a period of at to the lowest degree 12 months. These children had their adrenal function evaluated by early morning cortisol and low dose ACTH stimulation examination. None of the patients demonstrated any evidence of adrenal suppression (11).
The current guidelines for screening for adrenal insufficiency in the setting of ICS use recommend screening high risk patients including: chronic use of moderate to high dose of high potency ICS for longer than 6 months; concurrent use of inhaled or topical corticosteroids; frequent medication with oral glucocorticoids, and low torso mass index (BMI) (12). Screening may be washed by early on morning cortisol level and confirmation with depression dose ACTH stimulation examination if cortisol level is less than10 µg/dL (13,xiv).
Dynamic testing of HPA centrality
At that place are multiple provocative tests which may exist used for evaluation of the HPA axis. These provocative agents exam different levels of the HPA axis. Insulin tolerance exam (ITT) has long been considered the golden standard as information technology assesses the integrity of the full HPA axis. However, ITT has not been widely used in many institutions given the hazard of hypoglycemia and the usual presence of multiple contraindications. In addition, it can be resource intensive and expensive (15). Metyrapone stimulation exam is considered to be a sensitive test and comparable to ITT since it evaluates integrity of the HPA axis as a whole. It is based on the fact that metyrapone inhibits 11 hydroxylases, leading to decreased cortisol level, and thus stimulating the pituitary secretion of ACTH. The use of this test has been challenging due to unavailability of metyrapone and risk of inducing an adrenal crisis. The variation in ACTH assays and availability of 11 deoxycortisol assays brand this test a suboptimal modality for testing in these children (xvi,17).
ACTH stimulation exam provides an indirect cess of adrenal cortical role in the state of chronic ACTH deficiency. The loftier dose ACTH stimulation test (HDST) (250 µg) utilizes supra-physiologic doses of ACTH sufficient to stimulate atrophied adrenal glands, thus leading to false negative results. The low dose ACTH stimulation test (LDST) (1 µg) was believed to exist an appropriate solution this concern. However, there are some challenges in regards to techniques for dilution of the ACTH grooming due to lack of standardized protocols and cut off thresholds. This has led to controversies about the accuracy value of the exam. Multiple studies comparison low dose with high dose ACTH stimulation tests institute that LDST has higher sensitivity but lower specificity compared to the HDST (18). Suggestions have been made virtually increasing the cut off range for HDST to amend sensitivity of the test. Giordano et al. studied the sensitivity and specificity of different provocative tests in comparison to ITT in adults. They constitute that HDST cortisol cutoff of 37 µg/dL would make the exam 95% sensitive. For best pairs of values for highest sensitivity and specificity, they suggested a cortisol cutoff of 21 µg/dL for HDST compared to 17 µg/dL for the LDST (19).
The employ of glucagon equally a provocative agent for assessment of HPA axis has also been studied. Its utilise in conjunction with growth hormone (GH) cess in GH provocative testing protocols makes information technology especially useful. Bottner et al. reported that glucagon stimulation examination was comparable to testing with CRH and ITT in children. They suggested cortisol cutoff of 16 µg/dL for all-time pair of sensitivity and specificity (20). Some other cortisol cutoff was suggested at 14.six compared to xx µg/dL for ITT (21).
Conclusions
The widespread use of glucocorticoids for their potent anti-inflammatory and pharmacological effects comes at the run a risk of side effects such as secondary adrenal insufficiency. Identifying patients at high risk for developing adrenal insufficiency and the appropriate testing protocols is crucial to avert unnecessary glucocorticoid replacement on i hand, and missing a diagnosis of adrenal insufficiency with detrimental consequences on the other.
Use of exogenous glucocorticoids is known to cause suppression of the HPA axis. Secondary adrenal insufficiency may be noted with oral and inhaled glucocorticoid administration. Typically, the HPA axis recovers fairly quickly if glucocorticoids have been used for less than x–fourteen days. If glucocorticoids have been used for two weeks or longer then weaning of steroids and assessment of the integrity of the HPA centrality are recommended. In the meantime, patients should be educated about the employ of steroid coverage for stress until recovery of HPA axis is documented.
The optimal time to test for HPA axis recovery following prolonged glucocorticoid utilise remains controversial due to variability of data for timelines of when that occurs. In general, the primeval that HPA axis recovery may be seen is nigh 4 weeks post-cessation of prolonged glucocorticoid utilize. It would exist therefore reasonable to plan cess of HPA axis around that time and and so every 1–two months until recovery is documented. Early morning 8 AM cortisol level is useful screening examination especially with ICS. If early on morn cortisol level is <x µg/dL then further dynamic testing of the HPA axis needs to be considered. ITT is considered to be the aureate standard but is not widely used due to risk of side effects. Metyrapone stimulation examination is believed to be comparable to ITT and is a skillful culling test. However, the risk of adrenal crunch and limited availability of metyrapone itself brand this test less appealing. Low dose ACTH stimulation test is a highly sensitive exam for secondary adrenal insufficiency. It does non evaluate recovery of the axis at the hypothalamus and pituitary level. Moreover, at that place are some technical concerns nearly the dilution techniques and lack of standardized protocols for this testing which further complicate the issue. Glucagon stimulation exam is an alternative as well, but again there are different cortisol cutoff thresholds published which makes standardization hard. Therefore, low dose ACTH stimulation examination is a proficient examination with high sensitivity to assess the HPA axis.
Footnotes
Conflicts of Involvement: The authors have no conflicts of involvement to declare.
References
ane. Kannan CR. The Adrenal Gland. Springer, 2011. [Google Scholar]
2. Sperling MA. Pediatric Endocrinology. Fourth ed. Elsevier, 2014. [Google Scholar]
3. Felner EI, Thompson MT, Ratliff AF, et al. Time course of recovery of adrenal function in children treated for leukemia. J Pediatr 2000;137:21-4. x.1067/mpd.2000.107385 [PubMed] [CrossRef] [Google Scholar]
4. Mahachoklertwattana P, Vilaiyuk South, Hongeng S, et al. Suppression of adrenal office in children with astute lymphoblastic leukemia post-obit induction therapy with corticosteroid and other cytotoxic agents. J Pediatr 2004;144:736-40. ten.1016/S0022-3476(04)00233-1 [PubMed] [CrossRef] [Google Scholar]
5. Einaudi S, Bertorello N, Masera N, et al. Adrenal centrality function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. Pediatr Claret Cancer 2008;50:537-41. 10.1002/pbc.21339 [PubMed] [CrossRef] [Google Scholar]
half-dozen. Mendoza-Cruz AC, Wargon O, Adams Due south, et al. Hypothalamic-pituitary-adrenal axis recovery following prolonged prednisolone therapy in infants. J Clin Endocrinol Metab 2013;98:E1936-xl. x.1210/jc.2013-2649 [PubMed] [CrossRef] [Google Scholar]
seven. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 2011;204:479-87. ten.1016/j.ajog.2010.11.039 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
8. Blair J, Lancaster G, Titman A, et al. Early on morn salivary cortisol and cortisone, and adrenal responses to a simplified low-dose brusque Synacthen test in children with asthma. Clin Endocrinol (Oxf) 2014;80:376-83. x.1111/cen.12302 [PubMed] [CrossRef] [Google Scholar]
9. Schwartz RH, Neacsu O, Ascher DP, et al. Moderate dose inhaled corticosteroid-induced symptomatic adrenal suppression: case report and review of the literature. Clin Pediatr (Phila) 2012;51:1184-ninety. 10.1177/0009922812462235 [PubMed] [CrossRef] [Google Scholar]
10. Eid N, Morton R, Olds B, et al. Decreased forenoon serum cortisol levels in children with asthma treated with inhaled fluticasone propionate. Pediatrics 2002;109:217-21. 10.1542/peds.109.two.217 [PubMed] [CrossRef] [Google Scholar]
11. Breborowicz A, Niedziela G. Adrenal role in children with severe asthma treated with high-dose inhaled glucocorticoids: recommended screening tests in outpatient conditions. J Pediatr Endocrinol Metab 2007;xx:781-9. 10.1515/JPEM.2007.20.seven.781 [PubMed] [CrossRef] [Google Scholar]
12. Zollner EW, Lombard CJ, Galal U, et al. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children. Pediatrics 2012;130:e1512-9. x.1542/peds.2012-1147 [PubMed] [CrossRef] [Google Scholar]
thirteen. Issa-El-Khoury K, Kim H, Chan ES, et al. CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the direction of pediatric asthma. Allergy Asthma Clin Immunol 2015;11:9. 10.1186/s13223-015-0075-z [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
14. Lougheed MD, Lemiere C, Ducharme FM, et al. Canadian Thoracic Society 2012 guideline update: diagnosis and direction of asthma in preschoolers, children and adults. Can Respir J 2012;19:127-64. x.1155/2012/635624 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
15. Grinspoon SK, Biller BM. Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994;79:923-31. [PubMed] [Google Scholar]
16. Steiner H, Bahr V, Exner P, et al. Pituitary function tests: comparison of ACTH and eleven-deoxy-cortisol responses in the metyrapone test and with the insulin hypoglycemia test. Exp Clin Endocrinol 1994;102:33-viii. ten.1055/southward-0029-1211262 [PubMed] [CrossRef] [Google Scholar]
17. Spiger M, Jubiz W, Meikle AW, et al. Single-dose metyrapone examination: review of a 4-year experience. Curvation Intern Med 1975;135:698-700. x.1001/archinte.1975.00330050072012 [PubMed] [CrossRef] [Google Scholar]
18. Ng SM, Agwu JC, Dwan K. A systematic review and meta-analysis of Synacthen tests for assessing hypothalamic-pituitary-adrenal insufficiency in children. Arch Dis Child 2016;101:847-53. 10.1136/archdischild-2015-308925 [PubMed] [CrossRef] [Google Scholar]
nineteen. Giordano R, Picu A, Bonelli L, et al. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparing of dissimilar provocative tests. Clin Endocrinol (Oxf) 2008;68:935-41. 10.1111/j.1365-2265.2007.03141.x [PubMed] [CrossRef] [Google Scholar]
20. Bottner A, Kratzsch J, Liebermann S, et al. Comparison of adrenal role tests in children--the glucagon stimulation examination allows the simultaneous cess of adrenal role and growth hormone response in children. J Pediatr Endocrinol Metab 2005;eighteen:433-42. 10.1515/JPEM.2005.eighteen.five.433 [PubMed] [CrossRef] [Google Scholar]
21. di Iorgi N, Napoli F, Allegri A, et al. The accuracy of the glucagon test compared to the insulin tolerance test in the diagnosis of adrenal insufficiency in young children with growth hormone deficiency. J Clin Endocrinol Metab 2010;95:2132-9. 10.1210/jc.2009-2697 [PubMed] [CrossRef] [Google Scholar]
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682381/
0 Response to "Iatrogenic Adrenal Insufficiency How to Get Adrenals Working Again"
Post a Comment